Matrix metalloproteinase-13 promotes recovery from experimental liver cirrhosis in rats

Pathobiology

Volumn 78, Issue 5, 2011, Pages 239-252

  Endo, Hitoshi ^a   Niioka, Maki ^a   Sugioka, Yoshihiko ^b   Itoh, Johbu ^a   Kameyama, Kaori ^c   Okazaki, Isao ^d   Ala Aho, Risto ^e   Kähäri, Veli Matti ^e   Watanabe, Tetsu ^a  

^a TOKAI UNIVERSITY   (Japan)

^b ASAHIKAWA MEDICAL COLLEGE   (Japan)

^c KEIO UNIVERSITY   (Japan)

^d INTERNATIONAL UNIVERSITY OF HEALTH AND WELFARE   (Japan)

^e TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Adenoviral gene transfer; Extracellular matrix; Fibrosis; Hepatocyte growth factor; Interstitial collagenase; Matrix metalloproteinase(s)

Indexed keywords

ADENOVIRUS VECTOR; CARBON TETRACHLORIDE; COLLAGEN FIBER; COLLAGENASE 3; GELATINASE A; GELATINASE B; RECOMBINANT ADENOVIRUS MATRIX METALLOPROTEINASE 13; SCATTER FACTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; ENZYME ACTIVITY; GENE EXPRESSION; GENE TRANSFER; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER REGENERATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BLOTTING, WESTERN; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEPATOCYTE GROWTH FACTOR; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER CIRRHOSIS, EXPERIMENTAL; MALE; MATRIX METALLOPROTEINASE 13; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSFECTION;

ADENOVIRIDAE; RATTUS; RATTUS NORVEGICUS;

EID: 80051603154     PISSN: 10152008     EISSN: 14230291     Source Type: Journal    
DOI: 10.1159/000328841     Document Type: Article

References (48)

1. Seeff LB: Natural history of chronic hepatitis C. Hepatology 2002; 36:S35-S46. (Pubitemid 35253462)
2. Asselah T, Bieche I, Sabbagh A, Bedossa P, Moreau R, Valla D, Vidaud M, Marcellin P: Gene expression and hepatitis C virus infection. Gut 2009; 58: 846-858.
3. Rockey DC: Noninvasive assessment of liver fibrosis and portal hypertension with transient elastography. Gastroenterology 2008; 134: 8-14. (Pubitemid 350309358)
4. Friedman SL: Mechanisms of hepatic fibrogenesis. Gastroenterology 2008; 134: 1655-1669. (Pubitemid 351615417)
5. Yang C, Zeisberg M, Mosterman B, Sudhakar A, Yerramalla U, Holthaus K, Xu L, Eng F, Afdhal N, Kalluri R: Liver fibrosis: Insights into migration of hepatic stellate cells in response to extracellular matrix and growth factors. Gastroenterology 2003; 124: 147-159. (Pubitemid 36055348)
6. Bataller R, Brenner DA: Liver fibrosis. J Clin Invest 2005; 115: 209-218. (Pubitemid 40385459)
7. Hemmann S, Graf J, Roderfeld M, Roeb E: Expression of MMPs and TIMPs in liver fibrosis-a systematic review with special emphasis on anti-fibrotic strategies. J Hepatol 2007; 46: 955-975. (Pubitemid 46529049)
8. Vaillant B, Chiaramonte MG, Cheever AW, Soloway PD, Wynn TA: Regulation of hepatic fibrosis and extracellular matrix genes by the th response: new insight into the role of tissue inhibitors of matrix metalloproteinases. J Immunol 2001; 167: 7017-7026. (Pubitemid 33144197)
9. Mott JD, Werb Z: Regulation of matrix biology by matrix metalloproteinases. Curr Opin Cell Biol 2004; 16: 558-564. (Pubitemid 39201241)
10. Gonzalez-Avila G, Iturria C, Vadillo-Ortega F, Ovalle C, Montano M: Changes in matrix metalloproteinases during the evolution of interstitial renal fibrosis in a rat experimental model. Pathobiology 1998; 66: 196-204. (Pubitemid 28404331)
11. Kossakowska AE, Edwards DR, Lee SS, Urbanski LS, Stabbler AL, Zhang CL, Phillips BW, Zhang Y, Urbanski SJ: Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis. Am J Pathol 1998; 153: 1895-1902. (Pubitemid 28550676)
12. Iredale JP, Benyon RC, Pickering J, McCullen M, Northrop M, Pawley S, Hovell C, Arthur MJ: Mechanisms of spontaneous resolution of rat liver fibrosis: hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors. J Clin Invest 1998; 102: 538-549. (Pubitemid 28376157)
13. Quinn CO, Scott DK, Brinckerhoff CE, Matrisian LM, Jeffrey JJ, Partridge NC: Rat collagenase: cloning, amino acid sequence comparison, and parathyroid hormone regulation in osteoblastic cells. J Biol Chem 1990; 265: 22342-22347. (Pubitemid 120014307)
14. Hironaka K, Sakaida I, Matsumura Y, Kaino S, Miyamoto K, Okita K: Enhanced interstitial collagenase (matrix metalloproteinase-13) production of Kupffer cell by gadolinium chloride prevents pig serum-induced rat liver fibrosis. Biochem Biophys Res Commun 2000; 267: 290-295. (Pubitemid 30072544)
15. Watanabe T, Niioka M, Hozawa S, Sugioka Y, Arai M, Maruyama K, Okano H, Okazaki I: Stem cells expressing MMP-13 mRNA appear during regression reversal of hepatic cirrhosis; in Okazaki I, Ninomiya Y, Friedman SL, Tanikawa K (eds): Extracellular Matrix and the Liver: Approach to Gene Therapy. New York, Academic press, 2003, pp 361-388.
16. Watanabe T, Niioka M, Hozawa S, Kameyama K, Hayashi T, Arai M, Ishikawa A, Maruyama K, Okazaki I: Gene expression of interstitial collagenase in both progressive and recovery phase of rat liver fibrosis induced by carbon tetrachloride. J Hepatol 2000; 33: 224-235. (Pubitemid 30485226)
17. Fallowfield JA, Mizuno M, Kendall TJ, Constandinou CM, Benyon RC, Duffield JS, Iredale JP: Scar-associated macrophages are a major source of hepatic matrix metalloproteinase- and facilitate the resolution of murine hepatic fibrosis. J Immunol 2007; 178: 5288-5295. (Pubitemid 46595314)
18. Nakamura T, Torimura T, Sakamoto M, Hashimoto O, Taniguchi E, Inoue K, Sakata R, Kumashiro R, Murohara T, Ueno T, Sata M: Significance and therapeutic potential of endothelial progenitor cell transplantation in a cirrhotic liver rat model. Gastroenterology 2007; 133: 91-107. e1.
19. Dufour JF, DeLellis R, Kaplan MM: Regression of hepatic fibrosis in hepatitis C with long-term interferon treatment. Dig Dis Sci 1998; 43: 2573-2576. (Pubitemid 29034906)
20. Watanabe T, Niioka M, Ishikawa A, Hozawa S, Arai M, Maruyama K, Okada A, Okazaki I: Dynamic change of cells expressing MMP-mRNA and MT1-MMP mRNA in the recovery from liver fibrosis in the rat. J Hepatol 2001; 35: 465-473. (Pubitemid 32964445)
21. Ala-Aho R, Johansson N, Baker AH, Kahari VM: Expression of collagenase-3 (MMP-13) enhances invasion of human fibrosarcoma HT-1080 cells. Int J Cancer 2002; 97: 283-289. (Pubitemid 34049017)
22. Jackson KA, Snyder DS, Goodell MA: Skeletal muscle fiber-specific green autofluorescence: potential for stem cell engraftment artifacts. Stem Cells 2004; 22: 180-187. (Pubitemid 38282633)
23. Inomoto C, Umemura S, Egashira N, Minematsu T, Takekoshi S, Itoh Y, Itoh J, Taupenot L, OConnor DT, Osamura RY: Granulogenesis in non-neuroendocrine COS-7 cells induced by EGFP-tagged chromogranin a gene transfection: identical and distinct distribution of CgA and EGFP. J Histochem Cytochem 2007; 55: 487-493. (Pubitemid 46668630)
24. Ishikawa F, Shimazu H, Shultz LD, Fukata M, Nakamura R, Lyons B, Shimoda K, Shimoda S, Kanemaru T, Nakamura K, Ito H, Kaji Y, Perry AC, Harada M: Purified human hematopoietic stem cells contribute to the generation of cardiomyocytes through cell fusion. FASEB J 2006; 20: 950-952.
25. Endo H, Sugioka Y, Nakagi Y, Saijo Y, Yoshida T: A novel role of the nrf2 transcription factor in the regulation of arsenite-mediated keratin 16 gene expression in human keratinocytes. Environ Health Perspect 2008; 116: 873-879. (Pubitemid 351943893)
26. Endo H, Watanabe T, Sugioka Y, Niioka M, Inagaki Y, Okazaki I: Activation of two distinct MAPK pathways governs constitutive expression of matrix metalloproteinase-1 in human pancreatic cancer cell lines. Int J Oncol 2009; 35: 1237-1245.
27. Marchand-Adam S, Fabre A, Mailleux AA, Marchal J, Quesnel C, Kataoka H, Aubier M, Dehoux M, Soler P, Crestani B: Defect of prohepatocyte growth factor activation by fibroblasts in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2006; 174: 58-66. (Pubitemid 43955245)
28. Phin S, Marchand-Adam S, Fabre A, Marchal-Somme J, Bantsimba-Malanda C, Kataoka H, Soler P, Crestani B: Imbalance in the pro-hepatocyte growth factor activation system in bleomycin-induced lung fibrosis in mice. Am J Respir Cell Mol Biol 2010; 42: 286-293.
29. Kennedy AM, Inada M, Krane SM, Christie PT, Harding B, Lopez-Otin C, Sanchez LM, Pannett AA, Dearlove A, Hartley C, Byrne MH, Reed AA, Nesbit MA, Whyte MP, Thakker RV: MMP13 mutation causes spondyloepimetaphyseal dysplasia, missouri type (SEMD(MO)). J Clin Invest 2005; 115: 2832-2842. (Pubitemid 41434410)
30. Nakamura T, Akiyoshi H, Saito I, Sato K: Adenovirus-mediated gene expression in the septal cells of cirrhotic rat livers. J Hepatol 1999; 30: 101-106. (Pubitemid 29023658)
31. Ueki T, Kaneda Y, Tsutsui H, Nakanishi K, Sawa Y, Morishita R, Matsumoto K, Nakamura T, Takahashi H, Okamoto E, Fujimoto J: Hepatocyte growth factor gene therapy of liver cirrhosis in rats. Nat Med 1999; 5: 226-230. (Pubitemid 29068532)
32. Shiota G, Kawasaki H: Hepatocyte growth factor in transgenic mice. Int J Exp Pathol 1998; 79: 267-277. (Pubitemid 28481535)
33. Oyagi S, Hirose M, Kojima M, Okuyama M, Kawase M, Nakamura T, Ohgushi H, Yagi K: Therapeutic effect of transplanting HGFtreated bone marrow mesenchymal cells into CCl4-injured rats. J Hepatol 2006; 44: 742-748.
34. Kim WH, Matsumoto K, Bessho K, Nakamura T: Growth inhibition and apoptosis in liver myofibroblasts promoted by hepatocyte growth factor leads to resolution from liver cirrhosis. Am J Pathol 2005; 166: 1017-1028. (Pubitemid 40524427)
35. Siller-Lopez F, Sandoval A, Salgado S, Salazar A, Bueno M, Garcia J, Vera J, Galvez J, Hernandez I, Ramos M, Aguilar-Cordova E, Armendariz-Borunda J: Treatment with human metalloproteinase-8 gene delivery ameliorates experimental rat liver cirrhosis. Gastroenterology 2004; 126: 1122-1133, discussion 949. (Pubitemid 38451183)
36. Zhou HY, Wong AS: Activation of p70S6K induces expression of matrix metalloproteinase associated with hepatocyte growth factor-mediated invasion in human ovarian cancer cells. Endocrinology 2006; 147: 2557-2566.
37. Kermorgant S, Aparicio T, Dessirier V, Lewin MJ, Lehy T: Hepatocyte growth factor induces colonic cancer cell invasiveness via enhanced motility and protease overproduction: evidence for PI3 kinase and PKC involvement. Carcinogenesis 2001; 22: 1035-1042. (Pubitemid 32633601)
38. Iimuro Y, Nishio T, Morimoto T, Nitta T, Stefanovic B, Choi SK, Brenner DA, Yamaoka Y: Delivery of matrix metalloproteinase-1 attenuates established liver fibrosis in the rat. Gastroenterology 2003; 124: 445-458. (Pubitemid 36169261)
39. Knauper V, Lopez-Otin C, Smith B, Knight G, Murphy G: Biochemical characterization of human collagenase-3. J Biol Chem 1996; 271: 1544-1550. (Pubitemid 26028643)
40. Mohammed FF, Pennington CJ, Kassiri Z, Rubin JS, Soloway PD, Ruther U, Edwards DR, Khokha R: Metalloproteinase inhibitor TIMP-1 affects hepatocyte cell cycle via HGF activation in murine liver regeneration. Hepatology 2005; 41: 857-867. (Pubitemid 40462949)
41. Olle EW, Ren X, McClintock SD, Warner RL, Deogracias MP, Johnson KJ, Colletti LM: Matrix metalloproteinase-9 is an important factor in hepatic regeneration after partial hepatectomy in mice. Hepatology 2006; 44: 540-549. (Pubitemid 44433710)
42. Miyazawa K, Shimomura T, Naka D, Kitamura N: Proteolytic activation of hepatocyte growth factor in response to tissue injury. J Biol Chem 1994; 269: 8966-8970. (Pubitemid 24209213)
43. Naldini L, Tamagnone L, Vigna E, Sachs M, Hartmann G, Birchmeier W, Daikuhara Y, Tsubouchi H, Blasi F, Comoglio PM: Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor. EMBO J 1992; 11: 4825-4833. (Pubitemid 23023425)
44. Masumoto A, Yamamoto N: Sequestration of a hepatocyte growth factor in extracellular matrix in normal adult rat liver. Biochem Biophys Res Commun 1991; 174: 90-95.
45. Tang W, Miyazawa K, Kitamura N: Hepatocyte growth factor remains as an inactive single chain after partial hepatectomy or unilateral nephrectomy. FEBS Lett 1995; 362: 220-224.
46. Uchinami H, Seki E, Brenner DA, DArmiento J: Loss of MMP 13 attenuates murine hepatic injury and fibrosis during cholestasis. Hepatology 2006; 44: 420-429. (Pubitemid 44214881)
47. Kim EJ, Cho HJ, Park D, Kim JY, Kim YB, Park TG, Shim CK, Oh YK: Antifibrotic effect of MMP13-encoding plasmid DNA delivered using polyethylenimine shielded with hyaluronic acid. Mol Ther 2011; 19: 355-361.
48. Duffield JS, Forbes SJ, Constandinou CM, Clay S, Partolina M, Vuthoori S, Wu S, Lang R, Iredale JP: Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J Clin Invest 2005; 115: 56-65. (Pubitemid 40385505)